FDA Import Refusal SCS-4257877-5/11/1 — Ranbaxy Pharmaceuticals Canada
The FDA refused shipment SCS-4257877-5/11/1 from Ranbaxy Pharmaceuticals Canada (Canada) on Mar 1, 2021. The refused product falls under Drugs and Biologics — METFORMIN HCL (ANTI-DIABETIC). Cited charge: 75 This firm has 3 other import refusals on record.
Refusal details
- Date
- Mar 1, 2021
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY55 METFORMIN HCL (ANTI-DIABETIC)
- Charges
- 75